Teva Receives FDA Approval of Estazolam 1mg and 2mg Tablets.JERUSALEM, Israel--(BUSINESS WIRE)--July 11, 1997--Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVIY) today announced that it has received approval from the Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) to manufacture and market Estazolam 1mg and 2mg tablets. There is currently one other approved ANDA ANDA abbr. abbreviated new drug application for this product. Teva will commence shipment immediately. Estazolam is the generic equivalent of Abbott Laboratories' Prosam which is indicated for short-term management of insomnia with U.S. sales of approximately $15 million. Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in Ltd., is Israel's largest pharmaceutical company, with three-quarters of its sales outside Israel, mainly in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . The Company develops, manufactures and markets branded and generic human pharmaceutical chemicals, medical disposable and veterinary products. CONTACT: Dan Suesskind Chief Financial Officer (011) 9722-5-892-840 or Investor Relations Investor relations The process by which the corporation communicates with its investors. : Donna N. Stein Press: Richard Dukas Morgen-Walke Associates, Inc. (212) 850-5600 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion